Synthesis and Neurotoxicity of Tetrahydroisoquinoline Derivatives for Studying Parkinson's Disease

Parkinson's disease involves the progressive degeneration of dopaminergic neurons in the substantia nigra. However, the etiology of the disease remains to be elucidated. Endogenous amines, such as 1,2,3,4-tetrahydroisoquinoline (TIQ) derivatives present in the mammalian brain, are known to part...

Full description

Saved in:
Bibliographic Details
Published inBiological & Pharmaceutical Bulletin Vol. 28; no. 8; pp. 1355 - 1362
Main Authors Abe, Kenji, Saitoh, Toshiaki, Horiguchi, Yoshie, Utsunomiya, Iku, Taguchi, Kyoji
Format Journal Article
LanguageEnglish
Published Japan The Pharmaceutical Society of Japan 01.08.2005
Pharmaceutical Society of Japan
Japan Science and Technology Agency
Subjects
1,2,3,4-tetrahydroisoquinoline
1-benzyl-1,2,3,4-tetrahydroisoquinoline
1-methyl-1,2,3,4-tetrahydroisoquinoline
Humans
Parkinson Disease - metabolism
Parkinson's disease
Primates
Pummerer type cyclization
Stereoisomerism
Tetrahydroisoquinolines - chemical synthesis
Tetrahydroisoquinolines - chemistry
Tetrahydroisoquinolines - toxicity
Online AccessGet full text

Cover

Abstract Parkinson's disease involves the progressive degeneration of dopaminergic neurons in the substantia nigra. However, the etiology of the disease remains to be elucidated. Endogenous amines, such as 1,2,3,4-tetrahydroisoquinoline (TIQ) derivatives present in the mammalian brain, are known to participate in the pathogenesis of Parkinson's disease. These endogenous neurotoxins have been extensively studied because of their structural resemblance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), an agent widely used for generating animal models of Parkinson's disease-like symptoms. Investigations of the synthesis and pharmacological properties of TIQ derivatives are expected to contribute to the development of new therapeutic agents for treating Parkinson's disease. In the present study, we describe more efficient synthesis methods for TIQ derivatives via Pummerer-type cyclization of the substrate N-acyl sulfoxide. Furthermore, the modified Pummerer reaction provided a convenient and efficient method for synthesizing various TIQs. TIQ and its derivative, 1-benzyl-TIQ, can induce parkinsonism in primates and rodents. On the other hand, one TIQ derivative, 1-methyl-TIQ, has been shown to prevent MPTP, TIQ, and 1-benzyl-TIQ induced behavioral abnormalities. Therefore, TIQ derivatives are considered to play an important role in both the onset and prevention of Parkinson's disease. In this article, we focus on the synthesis and pharmacological aspects of 1,2,3,4-tetrahydroisoquinoline derivatives in Parkinson's disease.
AbstractList Parkinson's disease involves the progressive degeneration of dopaminergic neurons in the substantia nigra. However, the etiology of the disease remains to be elucidated. Endogenous amines, such as 1,2,3,4-tetrahydroisoquinoline (TIQ) derivatives present in the mammalian brain, are known to participate in the pathogenesis of Parkinson's disease. These endogenous neurotoxins have been extensively studied because of their structural resemblance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), an agent widely used for generating animal models of Parkinson's disease-like symptoms. Investigations of the synthesis and pharmacological properties of TIQ derivatives are expected to contribute to the development of new therapeutic agents for treating Parkinson's disease. In the present study, we describe more efficient synthesis methods for TIQ derivatives via Pummerer-type cyclization of the substrate N-acyl sulfoxide. Furthermore, the modified Pummerer reaction provided a convenient and efficient method for synthesizing various TIQs. TIQ and its derivative, 1-benzyl-TIQ, can induce parkinsonism in primates and rodents. On the other hand, one TIQ derivative, 1-methyl-TIQ, has been shown to prevent MPTP, TIQ, and 1-benzyl-TIQ induced behavioral abnormalities. Therefore, TIQ derivatives are considered to play an important role in both the onset and prevention of Parkinson's disease. In this article, we focus on the synthesis and pharmacological aspects of 1,2,3,4-tetrahydroisoquinoline derivatives in Parkinson's disease.
Parkinson's disease involves the progressive degeneration of dopaminergic neurons in the substantia nigra. However, the etiology of the disease remains to be elucidated. Endogenous amines, such as 1, 2, 3, 4-tetrahydroisoquinoline (TIQ) derivatives present in the mammalian brain, are known to participate in the pathogenesis of Parkinson's disease. These endogenous neurotoxins have been extensively studied because of their structural resemblance to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP), an agent widely used for generating animal models of Parkinson's disease-like symptoms. Investigations of the synthesis and pharmacological properties of TIQ derivatives are expected to contribute to the development of new therapeutic agents for treating Parkinson's disease. In the present study, we describe more efficient synthesis methods for TIQ derivatives via Pummerertype cyclization of the substrate N-acyl sulfoxide. Furthermore, the modified Pummerer reaction provided a convenient and efficient method for synthesizing various TIQs. TIQ and its derivative, 1-benzyl-TIQ, can induce parkinsonism in primates and rodents. On the other hand, one TIQ derivative, 1-methyl-TIQ, has been shown to prevent MPTP, TIQ, and 1-benzyl-TIQ induced behavioral abnormalities. Therefore, TIQ derivatives are considered to play an important role in both the onset and prevention of Parkinson's disease. In this article, we focus on the synthesis and pharmacological aspects of 1, 2, 3, 4-tetrahydroisoquinoline derivatives in Parkinson's disease.
Author Saitoh, Toshiaki
Taguchi, Kyoji
Horiguchi, Yoshie
Utsunomiya, Iku
Abe, Kenji
Author_xml – sequence: 1
  fullname: Abe, Kenji
  organization: Department of Neuroscience, Showa Pharmaceutical University
– sequence: 2
  fullname: Saitoh, Toshiaki
  organization: Department of Medicinal Chemistry, Showa Pharmaceutical University
– sequence: 3
  fullname: Horiguchi, Yoshie
  organization: Department of Medicinal Chemistry, Showa Pharmaceutical University
– sequence: 4
  fullname: Utsunomiya, Iku
  organization: Department of Neuroscience, Showa Pharmaceutical University
– sequence: 5
  fullname: Taguchi, Kyoji
  organization: Department of Neuroscience, Showa Pharmaceutical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16079473$$D View this record in MEDLINE/PubMed
BookMark eNpdkEtv1DAURi1URKeFFXsUCQkW1Qx-JLGzA7W0IFWA1LK2_LjpeMjYg-1U5N_jaaZUYnPvwsfnfvpO0JEPHhB6TfCK0Fp80Du9omJFWNM8QwvCar5sKGmO0AJ3RCxb0ohjdJLSBmPMMWUv0DFpMe9qzhZI30w-ryG5VClvq28wxpDDH2dcnqrQV7eQo1pPNgaXwu_R-TA4D9UFRHevsruHVPUhVjd5tJPzd9UPFX85n4J_n6oLl0AleIme92pI8OqwT9HPy8-351-W19-vvp5_ul4aTnFe9rSrTcmtBQZNaNvppoQUHVW97Y0mQDjhilBrO15r2zMuLCbAGRjVM9uwU_Ru9u5iSQopy61LBoZBeQhjkqSrKeekLeDb_8BNGKMv2SSp647VlIm97mymTAwpRejlLrqtipMkWO6Ll6V4SYXcF1_oNwfnqLdgn9hD0wW4moHy6owagt8X-XTZJK5dGIKkGDcSYyqwKIs96MtoKcG87Sgupo-zaZOyuoN_p1TMzgzwGEvM4-H745NZqyjBs7-KMa8m
CitedBy_id crossref_primary_10_1016_S1734_1140_10_70366_2
crossref_primary_10_1002_slct_201700051
crossref_primary_10_1007_s10600_017_1981_8
crossref_primary_10_1139_cjpp_2021_0659
crossref_primary_10_17721_1728_2748_2017_74_51_55
crossref_primary_10_1021_jo902502h
crossref_primary_10_1007_s12640_016_9661_1
crossref_primary_10_1002_ejoc_201100130
crossref_primary_10_1107_S1600536811038542
crossref_primary_10_1016_S1734_1140_12_70880_0
crossref_primary_10_3389_fphar_2023_1128496
crossref_primary_10_1111_j_1471_4159_2008_05774_x
crossref_primary_10_1002_ejoc_201901590
crossref_primary_10_1007_s00702_006_0546_y
crossref_primary_10_1007_s12640_019_00051_9
crossref_primary_10_1016_S1734_1140_13_71478_6
crossref_primary_10_1107_S2053229620009626
crossref_primary_10_3390_catal10080914
crossref_primary_10_1111_j_1471_4159_2006_03756_x
crossref_primary_10_1016_j_brainres_2010_01_049
crossref_primary_10_1016_j_molcata_2016_07_013
crossref_primary_10_1021_acs_joc_7b02584
crossref_primary_10_1016_j_pharep_2017_03_018
crossref_primary_10_1007_s12640_013_9440_1
crossref_primary_10_1016_j_crci_2012_05_016
crossref_primary_10_1007_s12640_009_9097_y
crossref_primary_10_1007_s12640_015_9556_6
crossref_primary_10_1002_rcm_3543
crossref_primary_10_1002_chem_200600735
crossref_primary_10_1007_s12640_010_9228_5
crossref_primary_10_1080_13543776_2017_1236084
crossref_primary_10_3390_molecules28020477
crossref_primary_10_3390_catal12101155
crossref_primary_10_1007_s12640_018_9939_6
crossref_primary_10_1107_S160053681103710X
crossref_primary_10_3390_antiox10060824
crossref_primary_10_1016_j_gresc_2021_11_005
crossref_primary_10_1016_j_lfs_2007_12_015
crossref_primary_10_1111_j_1476_5381_2011_01692_x
crossref_primary_10_1155_2009_969752
crossref_primary_10_1016_j_tet_2013_03_044
crossref_primary_10_1107_S1600536811015212
crossref_primary_10_1039_D2OB00340F
crossref_primary_10_1039_D2GC00636G
crossref_primary_10_2139_ssrn_4149179
crossref_primary_10_1016_j_ejmech_2005_11_003
crossref_primary_10_1002_jhet_4755
crossref_primary_10_3390_ijms222312805
crossref_primary_10_3390_molecules27249062
crossref_primary_10_1016_j_brainresbull_2016_02_007
crossref_primary_10_1002_ejoc_201600567
crossref_primary_10_1159_000371580
crossref_primary_10_3389_fphar_2022_917162
crossref_primary_10_1016_j_neuroscience_2009_03_009
Cites_doi 10.1016/0006-2952(79)90544-6
10.1016/0024-3205(85)90067-0
10.1016/0304-3940(95)12113-I
10.1016/0024-3205(88)90115-4
10.3987/S-1987-01-0359
10.1212/WNL.45.1.138
10.1016/S0092-8674(01)00407-X
10.1016/S0161-813X(03)00015-9
10.1046/j.1471-4159.1995.65062633.x
10.1016/0006-291X(86)91111-3
10.1016/S0006-8993(02)03894-5
10.1007/BF03159727
10.1021/jm950896w
10.1039/c39910000568
10.1016/S0306-4522(99)00533-3
10.1006/bbrc.1996.1289
10.1007/BF01517862
10.1002/cber.189302602143
10.1038/19899
10.1046/j.1471-4159.2001.00391.x
10.1002/cber.19110440309
10.2220/biomedres.8.453
10.1016/S0040-4020(01)91914-3
10.3987/R-1982-04-0653
10.1016/S0006-2952(01)00922-4
10.1006/bbrc.1997.6946
10.1007/978-1-4615-1269-1_2
10.1016/0006-8993(84)90777-7
10.1212/WNL.45.12.2240
10.1002/bms.1200190706
10.1021/jm00122a031
10.1111/j.1471-4159.1991.tb06407.x
10.1080/00397919608086750
10.1007/s007020170001
10.1248/cpb.51.667
10.1016/S0306-4522(99)00511-4
10.1016/S0006-291X(87)80075-X
10.1016/S0040-4020(01)87916-3
10.1016/S0306-4522(02)00789-3
10.1039/j39710002632
10.1021/jo982019e
10.1016/0304-3940(88)90166-8
10.1111/j.1471-4159.1987.tb05737.x
10.1126/science.1060627
10.1016/0014-4886(86)90070-1
10.1021/ja00188a040
10.1016/S0006-8993(97)01560-6
10.3987/COM-97-S70
10.1248/cpb.48.91
10.1016/S0006-2952(98)00142-7
10.1248/cpb.46.918
10.1021/ja01125a051
10.1002/ange.19840960627
10.1248/cpb.46.430
10.1248/cpb.16.953
10.1016/S0304-3940(96)13065-2
10.1248/cpb.39.1126
10.1016/0304-3940(88)90191-7
10.1016/S0040-4020(01)82421-2
10.1146/annurev.pa.20.040180.000415
10.1046/j.1471-4159.2001.00619.x
10.1016/j.brainres.2004.11.019
10.1016/0006-291X(89)91371-5
10.1016/0304-3940(90)90768-5
10.1002/cber.18930260191
10.3987/COM-03-S40
10.1016/0304-3940(85)90141-7
10.1159/000118535
10.1016/S0006-8993(01)02573-2
10.1126/science.6823561
10.1039/c39940001327
10.1016/S0361-9230(01)00603-7
10.1248/cpb.45.813
10.1021/jm00126a016
10.1021/jo00365a041
10.3987/COM-92-S14
10.1002/ana.410430503
10.1007/s007020050087
10.1016/S0021-9673(01)81439-4
10.1046/j.1471-4159.2000.0750065.x
10.1056/NEJM199810083391503
10.1111/j.1471-4159.1989.tb09170.x
10.1021/jo0155658
10.1007/BF00973651
10.1016/S0960-894X(03)00583-3
ContentType Journal Article
Copyright 2005 The Pharmaceutical Society of Japan
Copyright Japan Science and Technology Agency 2005
Copyright_xml – notice: 2005 The Pharmaceutical Society of Japan
– notice: Copyright Japan Science and Technology Agency 2005
CorporateAuthor aDepartment of Neuroscience
Showa Pharmaceutical University
bDepartment of Medicinal Chemistry
CorporateAuthor_xml – name: Showa Pharmaceutical University
– name: bDepartment of Medicinal Chemistry
– name: aDepartment of Neuroscience
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7QR
7TK
7U9
8FD
FR3
H94
P64
DOI 10.1248/bpb.28.1355
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitleList MEDLINE

Virology and AIDS Abstracts
Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-5215
EndPage 1362
ExternalDocumentID 3121240991
10_1248_bpb_28_1355
16079473
cs7biolo_2005_002808_003_1355_13621076920
article_bpb_28_8_28_8_1355_article_char_en
Genre Journal Article
Review
GroupedDBID ---
.55
1CY
23N
2WC
53G
5GY
6J9
AAUGY
ABTAH
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFFNX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKOMP
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
HH5
JMI
JSF
JSH
KQ8
MOJWN
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7M
XSB
ZXP
ZY4
ABJNI
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7QR
7TK
7U9
8FD
FR3
H94
P64
ID FETCH-LOGICAL-c720t-f294c215b80eb1269b5079892afdfcb1e1717a12dd974bdf378d01e73ecaf3d53
ISSN 0918-6158
IngestDate Fri Aug 16 10:28:32 EDT 2024
Thu Oct 10 15:44:12 EDT 2024
Fri Aug 23 01:08:40 EDT 2024
Sat Sep 28 08:36:02 EDT 2024
Fri May 31 15:04:18 EDT 2024
Thu Aug 17 20:27:29 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c720t-f294c215b80eb1269b5079892afdfcb1e1717a12dd974bdf378d01e73ecaf3d53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/bpb/28/8/28_8_1355/_article/-char/en
PMID 16079473
PQID 1449342385
PQPubID 1966364
PageCount 8
ParticipantIDs proquest_miscellaneous_19427716
proquest_journals_1449342385
crossref_primary_10_1248_bpb_28_1355
pubmed_primary_16079473
medicalonline_journals_cs7biolo_2005_002808_003_1355_13621076920
jstage_primary_article_bpb_28_8_28_8_1355_article_char_en
PublicationCentury 2000
PublicationDate 2005-08-01
PublicationDateYYYYMMDD 2005-08-01
PublicationDate_xml – month: 08
  year: 2005
  text: 2005-08-01
  day: 01
PublicationDecade 2000
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Biological & Pharmaceutical Bulletin
PublicationTitleAlternate Biol Pharm Bull
PublicationYear 2005
Publisher The Pharmaceutical Society of Japan
Pharmaceutical Society of Japan
Japan Science and Technology Agency
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: Pharmaceutical Society of Japan
– name: Japan Science and Technology Agency
References 77) Lang A. E., Lozano A. M., N. Engl. J. Med., 339, 1030—1053 (1998).
30) Pictet A., Spengler T., Ber., 44, 2030—2036 (1911).
59) Yamato M., Hashigaki K., Qais N., Ishikawa S., Tetrahedron, 46, 5909—5920 (1990).
36) Christiff J. J., Bradley L., Miller D. D., Lei L., Rodrigez F., Fraundorfer P., Romstedt K., Shams G., Feller D. R., J. Medicinal Chem., 40, 85—91 (1997).
45) Kessar S. V., Vohra R., Kaur N. P., Sihgh K. N., Sihgh P., J. Chem. Soc., Chem. Commun., 1994, 1327—1328 (1994).
56) Ohta S., Kohno M., Makino Y., Tachikawa O., Hirobe M., Biomed. Res., 8, 453—456 (1987).
71) Abe K., Taguchi K., Wasai T., Ren J., Utsunomiya I., Shinohara T., Miyatake T., Sano T., Brain Res. Bull., 56, 55—60 (2001).
79) Suzuki K., Mizuno Y., Yoshida M., Neurochem. Res., 15, 705—710 (1990).
16) Naoi M., Maruyama W., Eur. Neurol., 33 (Suppl. 1), 31—37 (1993).
10) Hao R., Ebadi M., Pfeiffer R. F., Neurosci. Lett., 200, 77—80 (1995).
73) Ishiwata K., Koyanagi Y., Abe K., Kawamura K., Taguchi K., Saitoh T., Toda J., Sano T., Brain Res., 960, 282—285 (2003).
4) Davis P. A., Baird-Lambert J., Taylor K. M., Maclaren J. A., Biochem. Pharmacol., 28, 1803—1806 (1979).
26) Makino Y., Ohta S., Tachikawa O., Hirobe M., Life Sci., 43, 373—378 (1988).
64) Toda J., Matsumoto S., Saitoh T., Sano T., Chem. Pharm. Bull., 48, 91—98 (2000).
66) Antkiewicz-Michaluk L., Romanska I., Papla I., Michaluk J., Bakalarz M., Vetulani J., Krygowska-Wajs A., Szczudlik A., Neuroscience, 96, 59—64 (2000).
6) Schneider J. S., Yuwiler A., Markham C. H., Exp. Neurol., 91, 293—307 (1986).
37) Bates H. A., Bagherir K., Vertino P. M., J. Org. Chem., 51, 3061—3063 (1986).
48) Takano S., Iida H., Inomata K., Ogasawara K., Heterocycles, 35, 47—52 (1993).
81) Ricaurte G. A., Langston J. W., DeLanney L. E., Irwin I., Brooks J. D., Neurosci. Lett., 59, 259—264 (1985).
29) Niwa T., Takeda N., Tatematsu A., Matsuura S., Yoshida M., Nagatsu T., J. Chromatogr., 452, 85—91 (1988).
40) Kametani T., Shibuya S., Satoh M., Chem. Pharm. Bull., 16, 953—957 (1968).
88) Ishiwata K., Koyanagi Y., Saitoh T., Taguchi K., Toda J., Sano T., Senda M., J. Neural Transm., 108, 1111—1125 (2001).
75) Uhl G. R., Ann. Neurol., 43, 555—560 (1998).
7) Jarvis M. F., Wagner G. C., Life Sci., 36, 249—254 (1985).
42) Scully F. E., Jr., Schlager J. J., Heterocycles, 19, 653—656 (1982).
46) Heer J. P., Harling J. D., Thompson M., Synthetic Commun., 32, 2555—2563 (2001).
78) Suzuki K., Mizuno Y., Yoshida M., Neurosci. Lett., 86, 105—108 (1988).
83) Kotake Y., Taguchi R., Okuda K., Sekiya K., Tasaki Y., Hirobe M., Ohta S., Brain Res., 1033, 143—150 (2005).
55) Makino Y., Tasaki Y., Ohta S., Hirobe M., Biomed. Environ. Mass Spectrom., 19, 415—419 (1990).
80) Parrado J., Absi E., Ayala A., Castano A., Cano J., Machado A., J. Neurochem., 75, 65—71 (2000).
27) Niwa T., Yoshizumi H., Tatematsu A., Matsuura S., Nagatsu T., J. Chromatogr., 493, 347—352 (1989).
92) Storch A., Ott S., Hwang Y. I., Ortmann R., Hein A., Frenzel S., Matsubara K., Ohta S., Wolf H. U., Schwarz J., Biochem. Pharmacol., 63, 909—920 (2002).
35) Venugopalan B., Brossi A., Heterocycles, 25, 359—364 (1987).
14) McNaught K. S., Carrupt P. A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C. D., Biochem. Pharmacol., 56, 921—933 (1998).
84) Kotake Y., Tasaki Y., Hirobe M., Ohta S., Brain Res., 787, 341—343 (1998).
25) Yoshida M., Niwa T., Nagatsu T., Neurosci. Lett., 119, 109—113 (1990).
3) Langston J. W., Ballard P., Tetrud J. W., Irwin I., Science, 219, 979—980 (1983).
15) Naoi M., Dostert P., Yoshida M., Nagatsu T., Adv. Neurol., 60, 212—217 (1993).
18) Niwa T., Takeda N., Sasaoka T., Kaneda N., Hashizume Y., Yoshizumi H., Tatematsu A., Nagatsu T., J. Chromatogr., 491, 397—403 (1989).
2) Shimura H., Schlossmacher M. G., Hattori N., Frosch M. P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K. S., Selkoe D. J., Science, 293, 263—269 (2001).
52) Meyers A. I., Fuentes L. M., Kubota Y., Tetrahedron, 40, 1361—1370 (1984).
41) Kametani T., Kigasawa K. Hiiragi M., Ishimaru H., J. Chem. Soc. Section C, 1971, 2632—2634 (1971).
67) Lorenc-Koci E., Smialowska M., Antkiewicz-Michaluk L., Golembiowska K., Bajkowska M., Wolfarth S., Neuroscience, 95, 1049—1059 (2000).
39) Kametani T., Fukumoto K., Aguri H., Yagi H., Kigasawa K., Sugahara H., Hiiragi M., Hyasaka T., Ishimaru H., J. Chem. Soc. Section C, 1998, 112—118 (1998).
76) Dunnett S. B., Björklund A., Nature (London), 399 (Suppl.), A32—A39 (1999).
21) Yamakawa T., Ohta S., Biochem. Biophys. Res. Commun., 236, 676—681 (1997).
47) Yokoyama A., Ohwada T., Shudo K., J. Org. Chem., 64, 611—617 (1999).
93) Okuda K., Kotake Y., Ohta S., Bioorg. Med. Chem. Lett., 13, 2853—2855 (2003).
8) Heikkila R. E., Sieber B. A., Manzino L., Sonsalla P. K., Mol. Chem. Neuropathol., 10, 171—183 (1989).
9) Hao R., Norgren R. B., Jr., Lau Y. S., Pfeiffer R. F., Neurology, 45, 138—142 (1995).
57) Ayala A., Parrado J., Cano J., Machado A., Brain Res., 638, 334—336 (1994).
28) Kikuchi K., Nagatsu Y., Makino Y., Mashino T., Ohta S., Hirobe M., Drug Metab. Dispos., 19, 257—262 (1991).
24) Tasaki Y., Makino Y., Ohta S., Hirobe M., J. Neurochem., 57, 1940—1943 (1991).
51) Shinohara T., Takeda A., Toda J., Ueda Y., Kohono M., Sano T., Chem. Pharm. Bull., 46, 918—917 (1998).
70) Booth R. G., Trevor A., Singer T. P., Castagnoli N., Jr., J. Med. Chem., 32, 473—477 (1989).
53) Meyers A. I., Boes M., Dickman D. A, Angew. Chem., 96, 448—449 (1984).
22) Kohno M., Ohta S., Hirobe M., Biochem. Biophys. Res. Commun., 140, 448—454 (1986).
89) Morikawa N., Naoi M., Maruyama W., Ohta S., Kotake Y., Kawai H., Niwa T., Dostert P., Mizuno Y., J. Neural Transm., 105, 677—688 (1998).
61) Adam S., Pannecoucke X., Comberet J.-C., Quirion J.-C., J. Org. Chem., 66, 8744—8750 (2001).
65) Saitoh T., Shikiya K., Horiguchi Y., Sano T., Chem. Pharm. Bull., 51, 667—672 (2003).
34) Graig P. N., Nabenhauer F. P., Williams P. M., Macko E., Toner J., J. Am. Chem. Soc., 74, 1316—1317 (1952).
31) Bischler A., Napieralski B., Ber., 26, 1903—1908 (1893).
90) Mizuno Y., Sone N., Saitoh T., J. Neurochem., 48, 1787—1793 (1987).
69) Ogawa M., Araki M., Nagatsu I., Nagatsu T., Yoshida M., Biogenic Amines, 6, 427—436 (1989).
85) Gray N. M., Cheng B. K., Mick S. J., Lair C. M., Contreras P. C., J. Med. Chem., 32, 1242—1248 (1989).
49) Shinohara T., Toda J., Sano T., Chem. Pharm. Bull., 45, 813—819 (1997).
63) Shinohara T., Takeda A., Toda J., Sano T., Chem. Pharm. Bull., 46, 430—433 (1998).
91) Shavali S., Ebadi M., Neurotoxicology, 24, 417—424 (2003).
20) Matsubara K., Kobayashi S., Kobayashi Y., Yamashita K., Koide H., Hatta M., Iwamoto K., Tanaka O., Kimura K., Neurology, 45, 2240—2245 (1995).
74) Storch A., Schwarz J., “Neorotoxic Factors in Parkinson's Disease and Related Disorders,” ed. by Storch A., Collins M. A., Plenum Press, New York, 2000, pp. 17—40.
5) Langston J. W., Forno L. S., Rebert C. S., Irwin I., Brain Res., 292, 390—394 (1984).
62) Ludwing M., Polborn K., Wanner K. T., Heterocycles, 61, 299—326 (2003).
86) Kotake Y., Ohta S., Kanazawa I., Sakurai M., Neuroscience, 117, 63—70 (2003).
54) Kotake Y., Yoshida M., Ogawa M., Tasaki Y., Hirobe M., Ohta S., Neurosci. Lett., 217, 69—71 (1996).
58) Rein K., Goicoechea-Pappas M., Anklekar T. V., Hart G. C., Smith G. A., Gawley R. E., J. Am. Chem. Soc., 111, 2211—2217 (1989).
82) Antkiewicz-Michaluk L., Michaluk J., Mokrosz M., Romanska I., Lorenc-Koci E., Ohta S., Vetulani J., J. Neurochem., 78, 100—108 (2001).
72) Ishiwata K., Koyanagi Y., Abe K., Kawamura K., Taguchi K., Saitoh T., Toda J., Senda M., Sano T., J. Neurochem., 79, 868—876 (2001).
1) Imai Y., Soda M., Inoue H., Hattori N., Mizuno Y., Takahashi R., Cell, 105, 891—902 (2001).
32) Pomeranz C., Monatsh. Chem., 14, 116—119 (1893).
19) Kotake Y., Tasaki Y., Makino Y., Ohta S., Hirobe M., J. Neurochem., 65, 2633—2638 (1995).
43) Seebach D., Lohmann J.-J., Syfrig M. A., Yoshifuji M., Tetrahedron, 39, 1963—1974 (1983).
38) Venkov A. P., Lukanov L. K., Synthetic Commun., 26, 755—762 (1996).
11) Deitrich R., Erwin V., Annu. Rev. Pharmacol. Toxicol., 20, 55—80 (1980).
60) Hashigaki K., Kan K., Qais N., Takeuchi Y., Yamato M., Chem. Pharm. Bull., 39, 1126—1131 (1991).
44) Kessar S. V., Sihgh P., Vohra R., Kaur N. P., Sihgh K. N., J. Chem. Soc., Chem. Commun., 1991, 568—570 (1991).
33) Fritsch P., Ber., 26, 419—428 (1893).
23) Nakagawa H., Nihonmatsu N., Ohta S., Hirobe M., Biochem. Biophys. Res. Commun., 225, 1027—1034 (1996).
13) Naoi M., Matsuura S., Parvez H., Takahashi T., Hirata Y., Minami M., Nagatsu T., J. Neurochem., 52, 653—655 (1989).
87) Abe K., Taguchi K., Wasai T., Ren J., Utsunomiya I., Shinohara T., Miyatake T., Sano T., Brain Res., 907, 134—138 (2001).
17) Niwa T., Takeda N., Kaneda N., Hashizume Y., Nagatsu T., Biochem. Biophys. Res. Commun., 144, 1084—1089 (1987).
68) Nagatsu T., Yoshida M., Neurosci. Lett., 87, 178—182 (1988).
12) Naoi M., Matsuura S., Takahashi T., Nagatsu T., Biochem. Biophys. Res. Commun., 161, 1213—1219 (1989).
50) Shinohara T., Takeda A., Toda J., Sano T., Heterocycles, 46, 555—565 (1997).
(28) 1991; 19
44
45
(55) 1990; 19
89
47
Kametani T., Fukumoto K., Aguri H. (39) 1998; 1998
SHINOHARA T (51) 1998; 46
TAKANO S (48) 1993; 35
Naoi M., Matsuura S., Parves H., Ta (13) 1989; 52
Mizuno Y., Sone N., Saitoh T. (90) 1987; 48
Matsubara K., Kobayashi S., Kobayas (20) 1995; 45
(38) 1996; 26
91
92
93
52
Storch A., Schwarz J. (74) 2000
10
54
OHTA S (56) 1987; 8
14
58
59
Fritsch P. (33) 1893; 26
Heer J. P., Harling J. D., Thompson (46) 2001; 32
Uhl G. R. (75) 1998; 43
Deitrich R., Erwin V. (11) 1980; 20
SHINOHARA T (63) 1998; 46
1
2
(19) 1995; 65
LUDWIG M (62) 2003; 61
3
4
5
7
(24) 1991; 57
Ogawa M., Araki M., Nagatsu I., Nag (69) 1989; 6
(37) 1986; 51
61
21
65
22
66
23
67
Schneider J. S., Yuwiler A., Markha (6) 1986; 91
68
26
SHINOHARA T (50) 1997; 46
29
Bischler A., Napieralski B. (31) 1893; 26
HASHIGAKI K (60) 1991; 39
Graig P. N., Nabenhauer F. P., Will (34) 1952; 74
(57) 1994; 638
Suzuki K., Mizuno Y., Yoshida M. (79) 1990; 15
71
72
Ricaurte G. A., Langston J. W., DeL (81) 1985; 59
(42) 1982; 19
76
77
36
Naoi M., Maruyama W. (16) 1993; 33
(70) 1989; 32
Naoi M., Dostert P., Yoshida M., Na (15) 1993; 60
(18) 1989; 491
VENUGOPALAN B (35) 1987; 25
Pictet A., Spengler T. (30) 1911; 44
TODA J (64) 2000; 48
Heikkila R. E., Sieber B. A., Manzi (8) 1989; 10
Suzuki K., Mizuno Y., Yoshida M. (78) 1988; 86
SHINOHARA T (49) 1997; 45
Yoshida M., Niwa T., Nagatsu T. (25) 1990; 119
Kametani T., Kigasawa K. Hiiragi M. (41) 1971; 1971
Meyers A. I., Boes M., Dickman D. A (53) 1984; 96
(12) 1989; 161
Ishiwata K., Koyanagi Y., Saitoh T. (88) 2001; 108
(17) 1987; 144
Kotake Y., Taguchi R., Okuda K., Se (83) 2005; 1033
Hao R., Norgren R. B., Jr., Lau Y. (9) 1995; 45
(27) 1989; 493
80
82
84
Pomeranz C. (32) 1893; 14
85
Ishiwata K., Koyanagi Y., Abe K., K (73) 2003; 960
86
Kametani T., Shibuya S., Satoh M. (40) 1968; 16
43
87
References_xml – ident: 4
  doi: 10.1016/0006-2952(79)90544-6
– ident: 7
  doi: 10.1016/0024-3205(85)90067-0
– ident: 10
  doi: 10.1016/0304-3940(95)12113-I
– volume: 32
  start-page: 2555
  issn: 0039-7911
  year: 2001
  ident: 46
  publication-title: Synthetic Commun.
  contributor:
    fullname: Heer J. P., Harling J. D., Thompson
– ident: 26
  doi: 10.1016/0024-3205(88)90115-4
– volume: 25
  start-page: 359
  issn: 0385-5414
  issue: Special Issue
  year: 1987
  ident: 35
  publication-title: Heterocycles
  doi: 10.3987/S-1987-01-0359
  contributor:
    fullname: VENUGOPALAN B
– volume: 45
  start-page: 138
  issn: 0028-3878
  year: 1995
  ident: 9
  publication-title: Neurology
  doi: 10.1212/WNL.45.1.138
  contributor:
    fullname: Hao R., Norgren R. B., Jr., Lau Y.
– ident: 1
  doi: 10.1016/S0092-8674(01)00407-X
– ident: 91
  doi: 10.1016/S0161-813X(03)00015-9
– volume: 65
  start-page: 2633
  issn: 0022-3042
  issue: 6
  year: 1995
  ident: 19
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1995.65062633.x
– ident: 22
  doi: 10.1016/0006-291X(86)91111-3
– volume: 960
  start-page: 282
  issn: 0006-8993
  year: 2003
  ident: 73
  publication-title: Brain Res.
  doi: 10.1016/S0006-8993(02)03894-5
  contributor:
    fullname: Ishiwata K., Koyanagi Y., Abe K., K
– volume: 10
  start-page: 171
  issn: 1044-7393
  year: 1989
  ident: 8
  publication-title: Mol. Chem. Neuropathol.
  doi: 10.1007/BF03159727
  contributor:
    fullname: Heikkila R. E., Sieber B. A., Manzi
– ident: 36
  doi: 10.1021/jm950896w
– ident: 44
  doi: 10.1039/c39910000568
– volume: 19
  start-page: 257
  issn: 0090-9556
  issue: 1
  year: 1991
  ident: 28
  publication-title: Drug Metab. Dispos.
– ident: 66
  doi: 10.1016/S0306-4522(99)00533-3
– ident: 23
  doi: 10.1006/bbrc.1996.1289
– volume: 14
  start-page: 116
  issn: 0026-9247
  year: 1893
  ident: 32
  publication-title: Monatsh. Chem.
  doi: 10.1007/BF01517862
  contributor:
    fullname: Pomeranz C.
– volume: 26
  start-page: 1903
  year: 1893
  ident: 31
  publication-title: Ber.
  doi: 10.1002/cber.189302602143
  contributor:
    fullname: Bischler A., Napieralski B.
– ident: 76
  doi: 10.1038/19899
– ident: 82
  doi: 10.1046/j.1471-4159.2001.00391.x
– volume: 44
  start-page: 2030
  year: 1911
  ident: 30
  publication-title: Ber.
  doi: 10.1002/cber.19110440309
  contributor:
    fullname: Pictet A., Spengler T.
– volume: 8
  start-page: 453
  issn: 0388-6107
  issue: 6
  year: 1987
  ident: 56
  publication-title: Biomed. Res.
  doi: 10.2220/biomedres.8.453
  contributor:
    fullname: OHTA S
– ident: 43
  doi: 10.1016/S0040-4020(01)91914-3
– volume: 19
  start-page: 653
  issn: 0385-5414
  issue: 4
  year: 1982
  ident: 42
  publication-title: Heterocycles
  doi: 10.3987/R-1982-04-0653
– ident: 92
  doi: 10.1016/S0006-2952(01)00922-4
– ident: 21
  doi: 10.1006/bbrc.1997.6946
– start-page: 17
  year: 2000
  ident: 74
  publication-title: Neorotoxic Factors in Parkinson's Disease and Related Disorders
  doi: 10.1007/978-1-4615-1269-1_2
  contributor:
    fullname: Storch A., Schwarz J.
– ident: 5
  doi: 10.1016/0006-8993(84)90777-7
– volume: 45
  start-page: 2240
  issn: 0028-3878
  year: 1995
  ident: 20
  publication-title: Neurology
  doi: 10.1212/WNL.45.12.2240
  contributor:
    fullname: Matsubara K., Kobayashi S., Kobayas
– volume: 19
  start-page: 415
  issn: 0887-6134
  issue: 7
  year: 1990
  ident: 55
  publication-title: Biomed. Environ. Mass Spectrom.
  doi: 10.1002/bms.1200190706
– volume: 32
  start-page: 473
  issn: 0022-2623
  issue: 2
  year: 1989
  ident: 70
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00122a031
– volume: 57
  start-page: 1940
  issn: 0022-3042
  issue: 6
  year: 1991
  ident: 24
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.1991.tb06407.x
– volume: 26
  start-page: 755
  issn: 0039-7911
  issue: 4
  year: 1996
  ident: 38
  publication-title: Synthetic Commun.
  doi: 10.1080/00397919608086750
– volume: 108
  start-page: 1111
  issn: 0300-9564
  year: 2001
  ident: 88
  publication-title: J. Neural Transm.
  doi: 10.1007/s007020170001
  contributor:
    fullname: Ishiwata K., Koyanagi Y., Saitoh T.
– ident: 65
  doi: 10.1248/cpb.51.667
– ident: 67
  doi: 10.1016/S0306-4522(99)00511-4
– volume: 144
  start-page: 1084
  issn: 0006-291X
  issue: 2
  year: 1987
  ident: 17
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/S0006-291X(87)80075-X
– ident: 59
  doi: 10.1016/S0040-4020(01)87916-3
– ident: 86
  doi: 10.1016/S0306-4522(02)00789-3
– volume: 1971
  start-page: 2632
  year: 1971
  ident: 41
  publication-title: J. Chem. Soc. Section C
  doi: 10.1039/j39710002632
  contributor:
    fullname: Kametani T., Kigasawa K. Hiiragi M.
– ident: 47
  doi: 10.1021/jo982019e
– ident: 68
  doi: 10.1016/0304-3940(88)90166-8
– volume: 48
  start-page: 1787
  issn: 0022-3042
  issue: 6
  year: 1987
  ident: 90
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.1987.tb05737.x
  contributor:
    fullname: Mizuno Y., Sone N., Saitoh T.
– ident: 2
  doi: 10.1126/science.1060627
– volume: 91
  start-page: 293
  issn: 0014-4886
  year: 1986
  ident: 6
  publication-title: Exp. Neurol.
  doi: 10.1016/0014-4886(86)90070-1
  contributor:
    fullname: Schneider J. S., Yuwiler A., Markha
– ident: 58
  doi: 10.1021/ja00188a040
– volume: 60
  start-page: 212
  issn: 0091-3952
  year: 1993
  ident: 15
  publication-title: Adv. Neurol.
  contributor:
    fullname: Naoi M., Dostert P., Yoshida M., Na
– volume: 491
  start-page: 397
  issn: 0021-9673
  issue: 2
  year: 1989
  ident: 18
  publication-title: J. Chromatogr.
– ident: 84
  doi: 10.1016/S0006-8993(97)01560-6
– volume: 46
  start-page: 555
  issn: 0385-5414
  year: 1997
  ident: 50
  publication-title: Heterocycles
  doi: 10.3987/COM-97-S70
  contributor:
    fullname: SHINOHARA T
– volume: 48
  start-page: 91
  issn: 0009-2363
  issue: 1
  year: 2000
  ident: 64
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.48.91
  contributor:
    fullname: TODA J
– ident: 14
  doi: 10.1016/S0006-2952(98)00142-7
– volume: 46
  start-page: 918
  issn: 0009-2363
  issue: 6
  year: 1998
  ident: 51
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.46.918
  contributor:
    fullname: SHINOHARA T
– volume: 74
  start-page: 1316
  issn: 0002-7863
  year: 1952
  ident: 34
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja01125a051
  contributor:
    fullname: Graig P. N., Nabenhauer F. P., Will
– volume: 96
  start-page: 448
  issn: 0044-8249
  year: 1984
  ident: 53
  publication-title: Angew. Chem.
  doi: 10.1002/ange.19840960627
  contributor:
    fullname: Meyers A. I., Boes M., Dickman D. A
– volume: 46
  start-page: 430
  issn: 0009-2363
  issue: 3
  year: 1998
  ident: 63
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.46.430
  contributor:
    fullname: SHINOHARA T
– volume: 16
  start-page: 953
  issn: 0009-2363
  year: 1968
  ident: 40
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.16.953
  contributor:
    fullname: Kametani T., Shibuya S., Satoh M.
– ident: 54
  doi: 10.1016/S0304-3940(96)13065-2
– volume: 638
  start-page: 334
  issn: 0006-8993
  issue: 1/2
  year: 1994
  ident: 57
  publication-title: Brain Res.
– volume: 39
  start-page: 1126
  issn: 0009-2363
  issue: 5
  year: 1991
  ident: 60
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.39.1126
  contributor:
    fullname: HASHIGAKI K
– volume: 86
  start-page: 105
  issn: 0304-3940
  year: 1988
  ident: 78
  publication-title: Neurosci. Lett.
  doi: 10.1016/0304-3940(88)90191-7
  contributor:
    fullname: Suzuki K., Mizuno Y., Yoshida M.
– volume: 493
  start-page: 347
  issn: 0021-9673
  issue: 2
  year: 1989
  ident: 27
  publication-title: J. Chromatogr.
– ident: 52
  doi: 10.1016/S0040-4020(01)82421-2
– volume: 20
  start-page: 55
  issn: 0362-1642
  year: 1980
  ident: 11
  publication-title: Annu. Rev. Pharmacol. Toxicol.
  doi: 10.1146/annurev.pa.20.040180.000415
  contributor:
    fullname: Deitrich R., Erwin V.
– ident: 72
  doi: 10.1046/j.1471-4159.2001.00619.x
– volume: 1033
  start-page: 143
  issn: 0006-8993
  year: 2005
  ident: 83
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2004.11.019
  contributor:
    fullname: Kotake Y., Taguchi R., Okuda K., Se
– volume: 161
  start-page: 1213
  issn: 0006-291X
  issue: 3
  year: 1989
  ident: 12
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/0006-291X(89)91371-5
– volume: 119
  start-page: 109
  issn: 0304-3940
  year: 1990
  ident: 25
  publication-title: Neurosci. Lett.
  doi: 10.1016/0304-3940(90)90768-5
  contributor:
    fullname: Yoshida M., Niwa T., Nagatsu T.
– volume: 26
  start-page: 419
  year: 1893
  ident: 33
  publication-title: Ber.
  doi: 10.1002/cber.18930260191
  contributor:
    fullname: Fritsch P.
– volume: 61
  start-page: 299
  issn: 0385-5414
  year: 2003
  ident: 62
  publication-title: Heterocycles
  doi: 10.3987/COM-03-S40
  contributor:
    fullname: LUDWIG M
– volume: 59
  start-page: 259
  issn: 0304-3940
  year: 1985
  ident: 81
  publication-title: Neurosci. Lett.
  doi: 10.1016/0304-3940(85)90141-7
  contributor:
    fullname: Ricaurte G. A., Langston J. W., DeL
– volume: 33
  start-page: 31
  issn: 0014-3022
  year: 1993
  ident: 16
  publication-title: Eur. Neurol.
  doi: 10.1159/000118535
  contributor:
    fullname: Naoi M., Maruyama W.
– ident: 87
  doi: 10.1016/S0006-8993(01)02573-2
– ident: 3
  doi: 10.1126/science.6823561
– ident: 45
  doi: 10.1039/c39940001327
– ident: 71
  doi: 10.1016/S0361-9230(01)00603-7
– volume: 45
  start-page: 813
  issn: 0009-2363
  issue: 5
  year: 1997
  ident: 49
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.45.813
  contributor:
    fullname: SHINOHARA T
– ident: 85
  doi: 10.1021/jm00126a016
– volume: 51
  start-page: 3061
  issn: 0022-3263
  issue: 15
  year: 1986
  ident: 37
  publication-title: J. Org. Chem.
  doi: 10.1021/jo00365a041
– volume: 35
  start-page: 47
  issn: 0385-5414
  issue: 1
  year: 1993
  ident: 48
  publication-title: Heterocycles
  doi: 10.3987/COM-92-S14
  contributor:
    fullname: TAKANO S
– volume: 6
  start-page: 427
  issn: 0168-8561
  year: 1989
  ident: 69
  publication-title: Biogenic Amines
  contributor:
    fullname: Ogawa M., Araki M., Nagatsu I., Nag
– volume: 43
  start-page: 555
  issn: 0364-5134
  year: 1998
  ident: 75
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.410430503
  contributor:
    fullname: Uhl G. R.
– ident: 89
  doi: 10.1007/s007020050087
– ident: 29
  doi: 10.1016/S0021-9673(01)81439-4
– volume: 1998
  start-page: 112
  year: 1998
  ident: 39
  publication-title: J. Chem. Soc. Section C
  contributor:
    fullname: Kametani T., Fukumoto K., Aguri H.
– ident: 80
  doi: 10.1046/j.1471-4159.2000.0750065.x
– ident: 77
  doi: 10.1056/NEJM199810083391503
– volume: 52
  start-page: 653
  issn: 0022-3042
  issue: 2
  year: 1989
  ident: 13
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.1989.tb09170.x
  contributor:
    fullname: Naoi M., Matsuura S., Parves H., Ta
– ident: 61
  doi: 10.1021/jo0155658
– volume: 15
  start-page: 705
  issn: 0364-3190
  year: 1990
  ident: 79
  publication-title: Neurochem. Res.
  doi: 10.1007/BF00973651
  contributor:
    fullname: Suzuki K., Mizuno Y., Yoshida M.
– ident: 93
  doi: 10.1016/S0960-894X(03)00583-3
SSID ssj0007023
ssib023156946
ssib002483627
ssib002822050
ssib017383521
Score 2.0908482
SecondaryResourceType review_article
Snippet Parkinson's disease involves the progressive degeneration of dopaminergic neurons in the substantia nigra. However, the etiology of the disease remains to be...
SourceID proquest
crossref
pubmed
medicalonline
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1355
SubjectTerms 1,2,3,4-tetrahydroisoquinoline
1-benzyl-1,2,3,4-tetrahydroisoquinoline
1-methyl-1,2,3,4-tetrahydroisoquinoline
Humans
Parkinson Disease - metabolism
Parkinson's disease
Primates
Pummerer type cyclization
Stereoisomerism
Tetrahydroisoquinolines - chemical synthesis
Tetrahydroisoquinolines - chemistry
Tetrahydroisoquinolines - toxicity
Title Synthesis and Neurotoxicity of Tetrahydroisoquinoline Derivatives for Studying Parkinson's Disease
URI https://www.jstage.jst.go.jp/article/bpb/28/8/28_8_1355/_article/-char/en
http://mol.medicalonline.jp/library/journal/download?GoodsID=cs7biolo/2005/002808/003&name=1355-1362e
https://www.ncbi.nlm.nih.gov/pubmed/16079473
https://www.proquest.com/docview/1449342385
https://search.proquest.com/docview/19427716
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Biological and Pharmaceutical Bulletin, 2005, Vol.28(8), pp.1355-1362
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLVGBQkkhGDKY6CAF1VZ0Bli52Fnx6i0KqgUJDJSd1EejpqiJqMmgwhfxudxbSdOIgoCNlEUO89zcn2v7XuM0C5PfOF5nMwFuA9zx074PIK4GUIVPyWR7WZUyS5-OPWOV877M_dsMvkxmLW0qeNF8v3avJL_QRWOAa4yS_YfkDUXhQOwD_jCFhCG7V9h_LkpwH-TkiKy-1vpbNTltzxpp1kEogZT0qRXZV6B_c-LUvmUb-HRviq9b6XFoKYSqmQnmQHdJoOxSupymqGbbtQ3N6ZSMmZ9PuoPj4dK3mpESbSZPxe56ciJwIKonpygrM5zcF8Nr-QSXXJlFtUoyEJDuVVdbWT2dKMc3XdfNqOuCtdMlGubEWj-e5slP0w_fPBqqVJNh_2ThENcq3XdF0JbZ9thEDnr_M_OfFM-oCkf2GJiawHgXxoJ6sjEh3gdLyhfdLXGUtynH8Oj1clJGByeBeNS3fQTaPGBzlI24QaVEoOqSegDL2aphQXNS7SZoXDn14P7jnyhmxcQDkidhzuXeohOS6X8PvJRHlBwD91tQxe81Dy8jyaimKLtZRHV5WWD97CaTKw-8xTdOugWEpyivU-aJ80-Dvpsv2pfnWKE05ttFBs-Y4ANj_iMywxfz2c84DMGPuOOz9jw-WWFWzY_QKujw-DgeN6uATJPGLXqeUZ9JwHEY26BV0E9P4YAxuc-jbI0S2IiCCMsIjRNITCO08xmPLWIYLZIosxOXfsh2irKQjxGmGZOFGWMQ0jiOYlgPBK27yYOzTI7snkyQ7sdGuFaS72EMkQG0EIALaQ8lKDNkK-RMpXa_7-rxPVG1jVFMoUSLNYMvRmBG7bGpAqTiinVNbksrBuqCQ9c6vbqyxBwM4nFPJ9aM7TT8aE_mziOL6U8OTzdC1MMMMvRv6gQ5Qbq-A5ljHgz9EizqH9JDz6pw-wnf770U3S7_6l30FZ9tRHPwCOv4-eK_D8Bqdrn5A
link.rule.ids 315,783,787,27937,27938
linkProvider ABC ChemistRy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+Neurotoxicity+of+Tetrahydroisoquinoline+Derivatives+for+Studying+Parkinson%27s+Disease&rft.jtitle=Biological+%26+pharmaceutical+bulletin&rft.au=Abe%2C+Kenji&rft.au=Saitoh%2C+Toshiaki&rft.au=Horiguchi%2C+Yoshie&rft.au=Utsunomiya%2C+Iku&rft.date=2005-08-01&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=0918-6158&rft.eissn=1347-5215&rft.volume=28&rft.issue=8&rft.spage=1355&rft_id=info:doi/10.1248%2Fbpb.28.1355&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3121240991
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-6158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-6158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-6158&client=summon